According to IMARC Group’s latest report, titled “Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, offers a comprehensive analysis of the industry, which comprises insights on the human growth hormone market growth.

The global human growth hormone market reached a value of US$ 4.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2027, exhibiting a CAGR of 8.47% during 2022-2027. Human growth hormone, also known as HGH, refers to a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. It generally regulates the regeneration, repair, reproduction, and metabolism of the cells, thereby contributing to the overall development of the body. Human growth hormone also manages body fluids, fat metabolism, bone and muscle growth, etc. The deficiency of HGH can increase the risk of chronic diseases and fat accumulation, whereas higher levels can cause gigantism and acromegaly, muscle-wasting disease, short bowel syndrome in adults, etc.

Download free sample brochure: https://www.imarcgroup.com/human-growth-hormone-market/requestsample

Human Growth Hormone Market Trends:

The growing prevalence of Turner syndrome, which is a chromosomal disorder distinguished by complete or partial loss of X chromosomes, is among the key factors stimulating the human growth hormone market. Moreover, growth hormones are usually administered to reverse some of the symptoms of this disease, thereby escalating the demand for HGH drugs across countries. Besides this, the increasing consumer health consciousness, the development of recombinant human growth hormone (rHGH), and the inflating need for preventive measures against endocrine disorders are positively influencing the global market. Furthermore, the rising occurrence of disorders, including Prader-Willi syndrome (PWS) and idiopathic short stature (ISS) that are caused by the deficiency of growth hormones in the body and can be treated by using medically synthesized medications, is acting as another significant growth-inducing factor. Apart from this, the widespread adoption of HGH as performance enhancers by bodybuilders is anticipated to fuel the human growth hormone market over the forecasted period.

Human Growth Hormone Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the human growth hormone market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Eli Lilly and Company
• EMD Serono Inc.
• F. Hoffmann-La Roche AG
• Ferring B.V.
• Genentech Inc.
• Ipsen
• Merck KGaA
• Novartis AG
• Novo Nordisk
• Pfizer Inc.
• Sandoz, etc.

Key Market Segmentation:

The report has segmented the global human growth hormone market on the basis of application, distribution channel, route of administration and region.

Breakup by Application:

• Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature (ISS)
• Prader-Willi Syndrome (PWS)
• Small for Gestational Age
• Others

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Breakup by Route of Administration:

• Intravenous
• Intramuscular
• Subcutaneous
• Oral

Breakup by Region:

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
• Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Ask Analyst for 10% free customized report:https://www.imarcgroup.com/human-growth-hormone-market

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.